| Adam M Glasgow, MD | |
|
900 Washington St Ste C, Norwood, MA 02062-3498 | |
| (508) 668-4400 | |
| (508) 668-4420 |
| Full Name | Adam M Glasgow |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 900 Washington St Ste C, Norwood, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427097518 | NPI | - | NPPES |
| 2192510 | Other | MA | US HEALTHCARE |
| 790609 | Other | MA | TUFTS HEALTH PLAN |
| 3181260 | Medicaid | MA | |
| 1700610 | Other | MA | UNITED HEALTH |
| 807915 | Other | MA | HARVARD PILGRIM HEALTH |
| J18784 | Other | MA | BLUE CROSS & BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 80651 (Massachusetts) | Primary |
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000007 |
News Archive
A pattern of genetic defects in tumours could indicate whether ovarian cancer patients will respond to common chemotherapy drugs before treatment starts, reveals a Cancer Research UK study published in the Proceedings of the National Academy of Sciences today (Monday).
Johns Hopkins researchers have devised a computerized process that could make minimally invasive surgery more accurate and streamlined using equipment already common in the operating room.
"Wars are less deadly than they once were and national mortality rates have continued to decline even during conflicts due to smaller scale fighting and better healthcare," according to a study released Wednesday by the Human Security Report Project, Reuters reports. "The report noted that most deaths in wars result from hunger and disease but said improved healthcare in peacetime had cut death tolls even during wartime, as had stepped up aid to people in war zones," according to the news service.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
› Verified 9 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000332 |
News Archive
A pattern of genetic defects in tumours could indicate whether ovarian cancer patients will respond to common chemotherapy drugs before treatment starts, reveals a Cancer Research UK study published in the Proceedings of the National Academy of Sciences today (Monday).
Johns Hopkins researchers have devised a computerized process that could make minimally invasive surgery more accurate and streamlined using equipment already common in the operating room.
"Wars are less deadly than they once were and national mortality rates have continued to decline even during conflicts due to smaller scale fighting and better healthcare," according to a study released Wednesday by the Human Security Report Project, Reuters reports. "The report noted that most deaths in wars result from hunger and disease but said improved healthcare in peacetime had cut death tolls even during wartime, as had stepped up aid to people in war zones," according to the news service.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
› Verified 9 days ago
| Entity Name | Surgical Weight Loss Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053616557 PECOS PAC ID: 3476737313 Enrollment ID: O20110418000506 |
News Archive
A pattern of genetic defects in tumours could indicate whether ovarian cancer patients will respond to common chemotherapy drugs before treatment starts, reveals a Cancer Research UK study published in the Proceedings of the National Academy of Sciences today (Monday).
Johns Hopkins researchers have devised a computerized process that could make minimally invasive surgery more accurate and streamlined using equipment already common in the operating room.
"Wars are less deadly than they once were and national mortality rates have continued to decline even during conflicts due to smaller scale fighting and better healthcare," according to a study released Wednesday by the Human Security Report Project, Reuters reports. "The report noted that most deaths in wars result from hunger and disease but said improved healthcare in peacetime had cut death tolls even during wartime, as had stepped up aid to people in war zones," according to the news service.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
› Verified 9 days ago
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20200204002341 |
News Archive
A pattern of genetic defects in tumours could indicate whether ovarian cancer patients will respond to common chemotherapy drugs before treatment starts, reveals a Cancer Research UK study published in the Proceedings of the National Academy of Sciences today (Monday).
Johns Hopkins researchers have devised a computerized process that could make minimally invasive surgery more accurate and streamlined using equipment already common in the operating room.
"Wars are less deadly than they once were and national mortality rates have continued to decline even during conflicts due to smaller scale fighting and better healthcare," according to a study released Wednesday by the Human Security Report Project, Reuters reports. "The report noted that most deaths in wars result from hunger and disease but said improved healthcare in peacetime had cut death tolls even during wartime, as had stepped up aid to people in war zones," according to the news service.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam M Glasgow, MD 900 Washington St Ste C, Norwood, MA 02062-3498 Ph: (508) 668-4400 | Adam M Glasgow, MD 900 Washington St Ste C, Norwood, MA 02062-3498 Ph: (508) 668-4400 |
News Archive
A pattern of genetic defects in tumours could indicate whether ovarian cancer patients will respond to common chemotherapy drugs before treatment starts, reveals a Cancer Research UK study published in the Proceedings of the National Academy of Sciences today (Monday).
Johns Hopkins researchers have devised a computerized process that could make minimally invasive surgery more accurate and streamlined using equipment already common in the operating room.
"Wars are less deadly than they once were and national mortality rates have continued to decline even during conflicts due to smaller scale fighting and better healthcare," according to a study released Wednesday by the Human Security Report Project, Reuters reports. "The report noted that most deaths in wars result from hunger and disease but said improved healthcare in peacetime had cut death tolls even during wartime, as had stepped up aid to people in war zones," according to the news service.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
› Verified 9 days ago
Lawrence C Unger, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 825 Washington St, Suite 220, Norwood, MA 02062 Phone: 781-762-2600 | |
Dr. Brian Frank Hinnebusch, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 128 Carnegie Row, Ste 208, Norwood, MA 02062 Phone: 781-551-5848 Fax: 781-352-4373 | |
Frederick Murray Gale, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 14 Cranmore Rd, Norwood, MA 02062 Phone: 617-459-5905 | |
Dr. Arthur Harry Glasgow, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3 Edgewater Dr, Suite 102, Norwood, MA 02062 Phone: 781-769-5550 Fax: 781-769-5356 | |
Timothy Michael Anderson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 825 Washington St, Suite # 115, Norwood, MA 02062 Phone: 781-769-2503 Fax: 781-769-2504 | |
John E Fattore, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 825 Washington St, Ste 390, Guild Medical Building, Norwood, MA 02062 Phone: 781-769-4077 |